The promise of pharmacogenetics: assessing the prospects for disease and patient stratification

&
Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):583-601 (2004)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1016/j.shpsc.2006.06.002

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,440

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.Andrew Smart & Paul Martin - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):583-601.
Tailored medicine: Whom will it fit? The ethics of patient and disease stratification.Andrew Smart, Paul Martin & Michael Parker - 2004 - Bioethics 18 (4):322–343.
Context, ethics and pharmacogenetics.Adam M. Hedgecoe - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):566-582.
Pharmacogenetics, Race and Global Injustice 1.Søren Holm - 2008 - Developing World Bioethics 8 (2):82-88.
Improving participant selection in disease management programmes: insights gained from propensity score stratification.Ariel Linden & John L. Adams - 2008 - Journal of Evaluation in Clinical Practice 14 (5):914-918.
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. [REVIEW]O. P. Corrigan - 2005 - Journal of Medical Ethics 31 (3):144-148.
Pharmacogenetics: Ethical issues and policy options.Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody - 2002 - Kennedy Institute of Ethics Journal 12 (1):1-15.
Non‐invasive risk stratification of coronary artery disease: an evaluation of some commonly used statistical classifiers in terms of predictive accuracy and clinical usefulness.Dario Gregori, Riccardo Bigi, Lauro Cortigiani, Francesco Bovenzi, Cesare Fiorentini & Eugenio Picano - 2009 - Journal of Evaluation in Clinical Practice 15 (5):777-781.
Tailor-made pharmacotherapy: Future developments and ethical challenges in the field of pharmacogenomics.Johannes Van Delden, Ineke Bolt, Annemarie Kalis, Jeroen Derijks & Hubert Leufkens - 2004 - Bioethics 18 (4):303–321.
Genetic databases and pharmacogenetics: introduction.Richard E. Ashcroft & Adam M. Hedgecoe - 2006 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 37 (3):499-502.
Genotyping the Future: Scientists' Expectations about Race/ Ethnicity after BiDil.Richard Tutton, Andrew Smart, Paul A. Martin, Richard Ashcroft & George T. H. Ellison - 2008 - Journal of Law, Medicine and Ethics 36 (3):464-470.
Variable meanings for the definition of disease.Harold Merskey - 1986 - Journal of Medicine and Philosophy 11 (3):215-232.
Chaos, Fractals, and Our Concept of Disease.Manuel Varela, Raul Ruiz-Esteban & Maria Jose Mestre De Juan - 2010 - Perspectives in Biology and Medicine 53 (4):584-595.
Improving efficiency and value in health care Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.Sunil Bhandari & Sarah Naudeer - 2008 - Journal of Evaluation in Clinical Practice 14 (6):996-1001.
The question not asked: The challenge of pleiotropic genetic tests.Robert Samuel Wachbroit - 1998 - Kennedy Institute of Ethics Journal 8 (2):131-144.

Analytics

Added to PP
2017-02-20

Downloads
9 (#1,232,561)

6 months
1 (#1,506,218)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

No references found.

Add more references